GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Gevo Inc (NAS:GEVO) » Definitions » Sloan Ratio %

Gevo (GEVO) Sloan Ratio % : -19.47% (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Gevo Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Gevo's Sloan Ratio for the quarter that ended in Dec. 2023 was -19.47%.

As of Dec. 2023, Gevo has a Sloan Ratio of -19.47%, indicating there is a warning stage of accrual build up.


Gevo Sloan Ratio % Historical Data

The historical data trend for Gevo's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gevo Sloan Ratio % Chart

Gevo Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.39 -9.82 62.04 -19.81 -19.47

Gevo Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.81 -36.32 -41.17 -29.30 -19.47

Competitive Comparison of Gevo's Sloan Ratio %

For the Specialty Chemicals subindustry, Gevo's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gevo's Sloan Ratio % Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Gevo's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Gevo's Sloan Ratio % falls into.



Gevo Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Gevo's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(-66.215--53.719
-114.129)/650.322
=-19.47%

Gevo's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(-66.215--53.719
-114.129)/650.322
=-19.47%

Gevo's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was -17.618 (Mar. 2023 ) + -14.42 (Jun. 2023 ) + -15.7 (Sep. 2023 ) + -18.477 (Dec. 2023 ) = $-66.22 Mil.
Gevo's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was -19.446 (Mar. 2023 ) + -9.933 (Jun. 2023 ) + 8.251 (Sep. 2023 ) + -32.591 (Dec. 2023 ) = $-53.72 Mil.
Gevo's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was 124.183 (Mar. 2023 ) + 15.341 (Jun. 2023 ) + -32.353 (Sep. 2023 ) + 6.958 (Dec. 2023 ) = $114.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gevo  (NAS:GEVO) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Gevo has a Sloan Ratio of -19.47%, indicating there is a warning stage of accrual build up.


Gevo Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Gevo's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Gevo (GEVO) Business Description

Traded in Other Exchanges
Address
345 Inverness Drive South, Building C, Suite 310, Englewood, CO, USA, 80112
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. Its operating segments are the Gevo segment, Renewable Natural Gas Segment, Net-Zero Segment and the Agri-Energy segment. By its segments, it is involved in research and development activities related to the future production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel. Gevo Development/Agri-Energy is the key revenue-generating segment that involves the operation of the Luverne Facility and production of ethanol, isobutanol and related products.
Executives
Andrew Shafer officer: Chief Mktg Cust & Brnd Officer C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH, BUILDING C, SUITE 310, ENGLEWOOD CO 80112
Alisher K Nurmat officer: VP and Controller C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH, BUILDING C, SUITE 310, ENGLEWOOD CO 80112
Angelo Amorelli director C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH, BUILDING C, SUITE 310, ENGLEWOOD CO 80112
Paul D Bloom officer: CCO & CIO C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH, BUILDING C, SUITE 310, ENGLEWOOD CO 80112
Kimberly T Bowron officer: Chief People Officer C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH, BUILDING C, SUITE 310, ENGLEWOOD CO 80112
Andrew Marsh director 968 ALBANY SHAKER ROAD, LATHAM NY 12110
Patrick R. Gruber director, officer: CEO & Director C/O GEVO, INC., 345 INVERNESS DR. SOUTH, BUILDING C, SUITE 310, ENGLEWOOD CO 80112
Christopher Michael Ryan officer: EVP, Business Development C/O GEVO, INC., 345 INVERNESS DR. SOUTH, BUILDING C, SUITE 310, ENGLEWOOD CO 80112
Timothy J Cesarek officer: Chief Commercial Officer 345 INVERNESS DRIVE SOUTH, BUILDING C, SUITE 310, ENGLEWOOD CO 80112
L Lynn Smull officer: Chief Financial Officer 345 INVERNESS DRIVE S, BLDG C, STE 310, ENGLEWOOD CO 80112
William H Baum director C/O DIVERSA CORP, 4955 DIRECTORS PLACE, SAN DIEGO CA 92121
Williams Geoffrey Thomas Jr. officer: General Counsel & Secretary 914 DAKOTA DRIVE, CASTLE ROCK CO 80108
Jaime Guillen director C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH, BUILDING C, SUITE 310, ENGLEWOOD CO 80112
Carol Jane Battershell director 1600 NORTH OAK STREET, #918, ARLINGTON VA 22209
Gary W. Mize director GEVO, INC., 345 INVERNESS DRIVE SOUTH, BUILDING C, SUITE 310, ENGLEWOOD CO 80112